These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37708619)

  • 1. False positive urine amphetamine immunoassay due to solriamfetol.
    Kumar G; Auckley D; Merrick T; Breckenridge M; Carter JC; Ali M
    Sleep Med; 2023 Oct; 110():297-299. PubMed ID: 37708619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening.
    Rackow AR; Knezevic CE
    J Anal Toxicol; 2024 Mar; 48(2):126-129. PubMed ID: 38048281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
    Weaver TE; Pepin JL; Schwab R; Shapiro C; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Bron M; Chandler P; Lee L; Malhotra A
    J Clin Sleep Med; 2021 Oct; 17(10):1995-2007. PubMed ID: 34606437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
    Powell J; Piszczatoski C; Garland S
    Ann Pharmacother; 2020 Oct; 54(10):1016-1020. PubMed ID: 32270686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
    Rosenberg R; Baladi M; Bron M
    J Clin Sleep Med; 2021 Apr; 17(4):711-717. PubMed ID: 33226332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
    Wang J; Yang S; Li X; Wang T; Xu Z; Xu X; Gao H; Chen G
    Sleep Med; 2021 Mar; 79():40-47. PubMed ID: 33472129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Malhotra A; Shapiro C; Pepin JL; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Chandler P; Lee L; Schwab R
    Sleep; 2020 Feb; 43(2):. PubMed ID: 31691827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
    Subedi R; Singh R; Thakur RK; K C B; Jha D; Ray BK
    Sleep Med; 2020 Nov; 75():510-521. PubMed ID: 33032062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness.
    Fuller MC; Carlson S; Pysick H; Berry V; Tondryk A; Swartz H; Cornett EM; Kaye AM; Viswanath O; Urits I; Kaye AD
    Psychopharmacol Bull; 2024 Mar; 54(1):65-86. PubMed ID: 38449471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy.
    Thorpy MJ; Hyman D; Parks GS; Chen A; Foley C; Baldys B; Ito D; Singh H
    Clin Ther; 2022 Oct; 44(10):1356-1369. PubMed ID: 36171171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario.
    Singh H; Hyman D; Parks GS; Chen A; Foley C; Baldys B; Ito D; Thorpy MJ
    Adv Ther; 2022 Sep; 39(9):4359-4373. PubMed ID: 35927541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.
    Abad VC; Guilleminault C
    Expert Rev Respir Med; 2018 Dec; 12(12):1007-1019. PubMed ID: 30365900
    [No Abstract]   [Full Text] [Related]  

  • 14. Solriamfetol for the Management of Excessive Daytime Sleepiness.
    Cuomo MC; Sheehan AH; Jordan JK
    J Pharm Pract; 2022 Dec; 35(6):963-970. PubMed ID: 33882756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays.
    Begeman A; Franssen EJF
    Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor.
    Baladi MG; Forster MJ; Gatch MB; Mailman RB; Hyman DL; Carter LP; Janowsky A
    J Pharmacol Exp Ther; 2018 Aug; 366(2):367-376. PubMed ID: 29891587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy.
    Yang J; Gao J
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):723-728. PubMed ID: 31215815
    [No Abstract]   [Full Text] [Related]  

  • 19. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
    Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L
    J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy.
    Schweitzer PK; Strohl KP; Mayer G; Rosenberg R; Chandler P; Baladi M; Lee L; Malhotra A
    J Clin Sleep Med; 2021 Apr; 17(4):659-668. PubMed ID: 33179591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.